Neurology: Volume 96, Number 19, May 11, 2021 Exam #1 - Association of Refractory Pain in the Acute Phase After Subarachnoid Hemorrhage With Continued Outpatient Opioid Use

About this course

  • Released: 05/11/2021
  • Expires: 05/11/2024

ASSOCIATION OF REFRACTORY PAIN IN THE ACUTE PHASE AFTER SUBARACHNOID HEMORRHAGE WITH CONTINUED OUTPATIENT OPIOID USE

LEARNING OBJECTIVES:

Upon completion of the article by Jaffa et al, the participant should be able to:
  • State the proportion of patients who endorsed ongoing use of opioid medications at a follow-up visit after a hospitalization for subarachnoid hemorrhage (SAH) in this study
  • Identify patient demographics or clinical factors that were associated with a higher odds of continued use of opioids at the time of discharge from a hospitalization for SAH in this study
  • Describe patient factors that were associated with the highest odds of continued use of opioids at the time of outpatient follow-up after a hospitalization for SAH in this study

CORE COMPETENCIES:

The article by Jaffa et al covers the following core competency:
  • Medical Knowledge


AUTHOR DISCLOSURES:

Refer to Information and Author section available in the Tool Bar for each article.

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

AMA CREDIT DESIGNATION STATEMENT

The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURES

James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology. Adam Kelly, MD, has served as a guest editor of Continuum (April 2014) and receives a stipend in his editorial capacity for Neurology.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

ACCME